Director, Clinical Pharmacy
Save this job and keep your search organized
Create a free account to save jobs, create alerts and return to this listing from your dashboard.
By continuing, you agree to our Terms & Privacy Policy.
Director, Clinical PharmacyAt UnitedHealthcare, we're simplifying the health care experience, creating healthier communities and removing barriers to quality care. The work you do here impacts the lives of millions of people for the better. Come build the health care system of tomorrow, making it more responsive, affordable and optimized. Ready to make a difference? Join us in making healthcare work better for everyone through people-led, responsible AI while Caring. Connecting. Growing together.
UnitedHealthcare is seeking an experienced oncology pharmacist to serve as a clinical and strategic leader for oncology medications across the medical and pharmacy benefits. This role will shape clinically sound, operationally feasible, and affordable coverage strategies while protecting appropriate member access and supporting providers, customers, and enterprise partners.
The Director, Clinical Pharmacy will be a primary pharmacy subject matter expert for the oncology portfolio, including the Cancer Guidance Program, oncology clinical policies and pathways, Prescription Drug List (PDL) and preferred-product strategies, utilization management, site-of-care optimization, medical drug exclusions, biosimilars, dose optimization, and emerging therapies. The pharmacist will translate rapidly evolving oncology evidence into practical coverage, program, and affordability recommendations and will help move those recommendations through governance and implementation.
You'll enjoy the flexibility to work remotely from anywhere within the U.S. as you take on some tough challenges.
Primary Responsibilities:
Lead clinical pharmacy strategy for oncology drugs covered under both the medical and pharmacy benefits, balancing evidence, safety, member access, provider impact, operational feasibility, and affordability.
Continuously evaluate FDA approvals, pivotal and real-world evidence, National Comprehensive Cancer Network (NCCN) recommendations, compendia, professional society guidance, comparative effectiveness, safety, sequencing, duration of therapy, and the oncology pipeline.
Assess newly launched therapies and existing treatment classes to identify clinically supported management opportunities, including preferred products, biosimilars, therapeutic alternatives, exclusions, dose rounding or banding, duration management, and site-of-care strategies.
Convert complex clinical findings into clear recommendations for clinical, operational, financial, executive, customer, and provider audiences.
Clinical policy, pathways, and governanceOwn or provide senior clinical oversight for oncology medication policies, related pathway maintenance, and supporting clinical criteria.
Develop, revise, and maintain prior authorization and medical-necessity criteria, policy language, coding considerations, and operational guidance for oncology therapies and supportive care medications.
Prepare and present oncology recommendations to the Pharmacy & Therapeutics Committee, PDL Management Committee, and Oncology Advisory Committee governance forums.
Coordinate pathway updates and related governance materials, documenting evidence, rationale, implementation impacts, and required stakeholder decisions.
Program leadership and operational partnershipServe as a key UnitedHealthcare pharmacy partner for the Cancer Guidance Program, including policy interpretation, prior authorization workflows, escalations, implementation readiness, and program enhancements.
Partner with oncology medical leadership and the oncology value creation team on Cancer Therapy Pathways and future oncology strategies.
Provide clinical leadership for oncology site-of-care initiatives, including drug and setting suitability, medication sourcing, provider considerations, network implications, and exception criteria for clinically complex patients.
Advance oncology affordability programs such as preferred-product strategies, biosimilar adoption, medical drug exclusions, dose optimization, and duration management while monitoring for unintended member or provider disruption.
Analytics, trend, and affordabilityUse utilization, claims, market share, prescribing, reimbursement, and financial information to evaluate oncology trend drivers and quantify management opportunities.
Partner with PDL strategy, contracting, analytics, specialty pharmacy, network, and medical cost teams to develop recommendations that balance savings, affordability, access, and provider feasibility.
Monitor program performance and clinical outcomes; identify leakage, exceptions, operational barriers, and opportunities for iterative improvement.